Tioga Pharmaceuticals, Inc.
www.tiogapharma.comTioga Pharmaceuticals is planning to conduct a phase 2 trial of its selective kappa-opioid receptor agonist, asimadoline, for the treatment of associated with atopic pruritus.
Read more
Tioga Pharmaceuticals is planning to conduct a phase 2 trial of its selective kappa-opioid receptor agonist, asimadoline, for the treatment of associated with atopic pruritus.
Read more
Country
State
California
City (Headquarters)
San Diego
Industry
Employees
11-50
Estimated Revenue
$10,000,000 to $50,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Executive Chair
Email ****** @****.comPhone (***) ****-****
Technologies
(3)
Reach decision makers at Tioga Pharmaceuticals, Inc.
Free credits every month!
Tioga Pharmaceuticals, Inc. FAQ
San Diego, United States
Pharmaceutical Manufacturing
